Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia

[1]  A. Meyer-Lindenberg,et al.  Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability. , 2009, Archives of general psychiatry.

[2]  Kiralee M. Hayashi,et al.  Time-lapse mapping of cortical changes in schizophrenia with different treatments. , 2009, Cerebral cortex.

[3]  J. Rapoport,et al.  Remission status and cortical thickness in childhood-onset schizophrenia. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

[4]  Monte S. Buchsbaum,et al.  Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients , 2008, Schizophrenia Research.

[5]  J. Rapoport,et al.  Clozapine use in children and adolescents , 2008, Expert opinion on pharmacotherapy.

[6]  Hilleke E. Hulshoff Pol,et al.  Progressive Brain Volume Loss in Schizophrenia Over the Course of the Illness: Evidence of Maturational Abnormalities in Early Adulthood , 2008, Biological Psychiatry.

[7]  Nitin Gogtay,et al.  Cortical Brain Development in Schizophrenia: Insights From Neuroimaging Studies in Childhood-Onset Schizophrenia , 2007, Schizophrenia bulletin.

[8]  Kiralee M. Hayashi,et al.  Dynamic mapping of cortical development before and after the onset of pediatric bipolar illness. , 2007, Journal of child psychology and psychiatry, and allied disciplines.

[9]  Deanna Greenstein,et al.  Cortical brain development in nonpsychotic siblings of patients with childhood-onset schizophrenia. , 2007, Archives of general psychiatry.

[10]  J. Rapoport,et al.  Longitudinal brain changes in early-onset psychosis. , 2007, Schizophrenia bulletin.

[11]  W. Honer,et al.  Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine. , 2006, The American journal of psychiatry.

[12]  J. Rapoport,et al.  Childhood onset schizophrenia: cortical brain abnormalities as young adults. , 2006, Journal of child psychology and psychiatry, and allied disciplines.

[13]  J. Rapoport,et al.  Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison. , 2006, Archives of general psychiatry.

[14]  J. Lieberman,et al.  Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. , 2006, The American journal of psychiatry.

[15]  Peter Falkai,et al.  Effects of antipsychotics on brain structure , 2006, Current opinion in psychiatry.

[16]  L. DeLisi,et al.  Understanding structural brain changes in schizophrenia , 2006, Dialogues in clinical neuroscience.

[17]  M. Desco,et al.  Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia , 2005, Schizophrenia Research.

[18]  M. Desco,et al.  Structural neuroimaging in adolescents with a first psychotic episode. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.

[19]  J. Lieberman,et al.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.

[20]  Zhuoxin Sun,et al.  The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys , 2005, Neuropsychopharmacology.

[21]  Alan C. Evans,et al.  Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification , 2005, NeuroImage.

[22]  James D. Christensen,et al.  Cerebral Cortical Gray Expansion Associated with Two Second-Generation Antipsychotics , 2005, Biological Psychiatry.

[23]  John Suckling,et al.  Different Effects of Typical and Atypical Antipsychotics on Grey Matter in First Episode Psychosis: the ÆSOP Study , 2005, Neuropsychopharmacology.

[24]  J. Lieberman,et al.  Antipsychotic drug effects on brain morphology in first-episode psychosis. , 2005, Archives of general psychiatry.

[25]  Alan C. Evans,et al.  Cortical thickness analysis examined through power analysis and a population simulation , 2005, NeuroImage.

[26]  L. DeLisi,et al.  Cerebral ventricular change over the first 10 years after the onset of schizophrenia , 2004, Psychiatry Research: Neuroimaging.

[27]  Vincent Magnotta,et al.  Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. , 2003, Archives of general psychiatry.

[28]  Alan C. Evans,et al.  Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis , 2002, IEEE Transactions on Medical Imaging.

[29]  Thomas E. Nichols,et al.  Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate , 2002, NeuroImage.

[30]  J. Rapoport,et al.  Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Alan C. Evans,et al.  Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. , 2001, Archives of general psychiatry.

[32]  Alan C. Evans,et al.  Automated 3-D Extraction of Inner and Outer Surfaces of Cerebral Cortex from MRI , 2000, NeuroImage.

[33]  Jay N Giedd,et al.  Childhood-onset schizophrenia: progressive brain changes during adolescence , 1999, Biological Psychiatry.

[34]  N C Andreasen,et al.  Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. , 1999, The American journal of psychiatry.

[35]  J. Rapoport,et al.  Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. , 1999, Archives of general psychiatry.

[36]  R. Gur,et al.  Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. , 1998, The American journal of psychiatry.

[37]  J N Giedd,et al.  Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. , 1998, The American journal of psychiatry.

[38]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.

[39]  J. Rapoport,et al.  Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. , 1996, Archives of general psychiatry.

[40]  M. Keshavan,et al.  Changes in caudate volume with neuroleptic treatment , 1994, The Lancet.

[41]  J. Lieberman,et al.  Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. , 1994, The American journal of psychiatry.

[42]  J. Rapoport,et al.  Childhood-onset schizophrenia: timely neurobiological research. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

[43]  J. Kane.  Clinical Efficacy of Clozapine in Treatment-Refractory Schizophrenia: An Overview , 1992, British Journal of Psychiatry.

[44]  G Honigfeld,et al.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. , 1988, Archives of general psychiatry.

[45]  Carmen Moreno,et al.  Progression of brain volume changes in adolescent-onset psychosis. , 2009, Schizophrenia bulletin.

[46]  Thomas F. Nugent,et al.  Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses. , 2004, Archives of general psychiatry.